{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T03:22:36Z","timestamp":1775445756712,"version":"3.50.1"},"reference-count":80,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Minnesota Partnership for Biotechnology and Medical Genomics","award":["K23MH082121"],"award-info":[{"award-number":["K23MH082121"]}]},{"name":"Minnesota Partnership for Biotechnology and Medical Genomics","award":["K23MH112867"],"award-info":[{"award-number":["K23MH112867"]}]},{"name":"Minnesota Partnership for Biotechnology and Medical Genomics","award":["LEND-HSRA T73MC12835"],"award-info":[{"award-number":["LEND-HSRA T73MC12835"]}]},{"name":"Minnesota Partnership for Biotechnology and Medical Genomics","award":["00063616"],"award-info":[{"award-number":["00063616"]}]},{"name":"Klarman Family Foundation","award":["K23MH082121"],"award-info":[{"award-number":["K23MH082121"]}]},{"name":"Klarman Family Foundation","award":["K23MH112867"],"award-info":[{"award-number":["K23MH112867"]}]},{"name":"Klarman Family Foundation","award":["LEND-HSRA T73MC12835"],"award-info":[{"award-number":["LEND-HSRA T73MC12835"]}]},{"name":"Klarman Family Foundation","award":["00063616"],"award-info":[{"award-number":["00063616"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Oxytocin (OT), a mammalian neurohormone associated with social cognition and behavior, can be administered in its synthetic form intranasally (IN) and impact brain chemistry and behavior. IN-OT shows potential as a noninvasive intervention for disorders characterized by social challenges, e.g., autism spectrum disorder (ASD) and anorexia nervosa (AN). To evaluate IN-OT\u2019s efficacy, we must quantify OT uptake, availability, and clearance; thus, we assessed OT levels in urine (uOT) before and after participants (26 ASD, 7 AN, and 7 healthy controls) received 40 IU IN-OT or placebo across two sessions using double-blind, placebo-controlled crossover designs. We also measured uOT and plasma (pOT) levels in a subset of participants to compare the two sampling methods. We found significantly higher uOT and pOT following intranasal delivery of active compound versus placebo, but analyses yielded larger effect sizes and more clearly differentiated pre\u2013post-OT levels for uOT than pOT. Further, we applied a two-step cluster (TSC), blinded backward-chaining approach to determine whether active\/placebo groups could be identified by uOT and pOT change alone; uOT levels may serve as an accessible and accurate systemic biomarker for OT dose\u2013response. Future studies will explore whether uOT levels correlate directly with behavioral targets to improve dosing for therapeutic goals.<\/jats:p>","DOI":"10.3390\/pharmaceutics14061178","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T09:24:29Z","timestamp":1653989069000},"page":"1178","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Utility of Downstream Biomarkers to Assess and Optimize Intranasal Delivery of Oxytocin"],"prefix":"10.3390","volume":"14","author":[{"given":"Megan","family":"DuBois","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4838-9452","authenticated-orcid":false,"given":"Angela","family":"Tseng","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunday M.","family":"Francis","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann F.","family":"Haynos","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol B.","family":"Peterson","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suma","family":"Jacob","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/978-1-61779-310-3_20","article-title":"Intranasal Delivery of Neuropeptides","volume":"789","author":"Veronesi","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.biopsych.2015.05.003","article-title":"Intranasal Oxytocin: Myths and Delusions","volume":"79","author":"Leng","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.brainres.2014.01.021","article-title":"Oxytocin and Vasopressin Systems in Genetic Syndromes and Neurodevelopmental Disorders","volume":"1580","author":"Francis","year":"2014","journal-title":"Brain Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41380-020-00864-7","article-title":"Advances in the Field of Intranasal Oxytocin Research: Lessons Learned and Future Directions for Clinical Research","volume":"26","author":"Quintana","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.schres.2018.07.003","article-title":"Peripheral Oxytocin and Vasopressin Modulates Regional Brain Activity Differently in Men and Women with Schizophrenia","volume":"202","author":"Rubin","year":"2018","journal-title":"Schizophr. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.psyneuen.2017.10.014","article-title":"Intranasal Oxytocin in the Treatment of Anorexia Nervosa: Randomized Controlled Trial during Re-Feeding","volume":"87","author":"Russell","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.cpr.2007.07.001","article-title":"Anxiety in the Eating Disorders: Understanding the Overlap","volume":"28","author":"Pallister","year":"2008","journal-title":"Clin. Psychol. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11920-017-0791-9","article-title":"Autism Spectrum Disorder in Anorexia Nervosa: An Updated Literature Review","volume":"19","author":"Westwood","year":"2017","journal-title":"Curr. Psychiatry Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.psyneuen.2014.07.014","article-title":"A Meta-Analytic Review of the Impact of Intranasal Oxytocin Administration on Cortisol Concentrations during Laboratory Tasks: Moderation by Method and Mental Health","volume":"49","author":"Cardoso","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/jcpp.12305","article-title":"The Effects of a Course of Intranasal Oxytocin on Social Behaviors in Youth Diagnosed with Autism Spectrum Disorders: A Randomized Controlled Trial","volume":"56","author":"Guastella","year":"2015","journal-title":"J. Child Psychol. Psychiatry"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/mp.2015.162","article-title":"The Effect of Oxytocin Nasal Spray on Social Interaction Deficits Observed in Young Children with Autism: A Randomized Clinical Crossover Trial","volume":"21","author":"Yatawara","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"8119","DOI":"10.1073\/pnas.1705521114","article-title":"Intranasal Oxytocin Treatment for Social Deficits and Biomarkers of Response in Children with Autism","volume":"114","author":"Parker","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.biopsych.2013.02.007","article-title":"Effects of Intranasal Oxytocin on the Neural Basis of Face Processing in Autism Spectrum Disorder","volume":"74","author":"Domes","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1056\/NEJMoa2103583","article-title":"Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder","volume":"385","author":"Sikich","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neubiorev.2020.12.028","article-title":"Intranasal Oxytocin in the Treatment of Autism Spectrum Disorders: A Multilevel Meta-Analysis","volume":"122","author":"Huang","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_16","unstructured":"(2022, April 15). ClinicalTrials.gov, Available online: https:\/\/www.clinicaltrials.gov\/ct2\/home."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.schres.2013.01.001","article-title":"Effects of Adjunctive Intranasal Oxytocin on Olfactory Identification and Clinical Symptoms in Schizophrenia: Results from a Randomized Double Blind Placebo Controlled Pilot Study","volume":"145","author":"Lee","year":"2013","journal-title":"Schizophr. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1038\/npp.2015.78","article-title":"Effects of Oxytocin on Neural Response to Facial Expressions in Patients with Schizophrenia","volume":"40","author":"Shin","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.biopsych.2016.11.012","article-title":"Intranasal Oxytocin to Prevent Posttraumatic Stress Disorder Symptoms: A Randomized Controlled Trial in Emergency Department Patients","volume":"81","author":"Frijling","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/scan\/nsx107","article-title":"Divergent Effects of Oxytocin on (para-)limbic Reactivity to Emotional and Neutral Scenes in Females with and without Borderline Personality Disorder","volume":"12","author":"Lischke","year":"2017","journal-title":"Soc. Cogn. Affect. Neurosci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1038\/npp.2010.123","article-title":"Oxytocin Attenuates Amygdala Reactivity to Fear in Generalized Social Anxiety Disorder","volume":"35","author":"Labuschagne","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/npp.2017.226","article-title":"Effects of Intranasal Oxytocin on the Blood Oxygenation Level-Dependent Signal in Food Motivation and Cognitive Control Pathways in Overweight and Obese Men","volume":"43","author":"Plessow","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"110098","DOI":"10.1016\/j.pnpbp.2020.110098","article-title":"Oxytocin Effects on the Cognition of Women with Postpartum Depression: A Randomized, Placebo-Controlled Clinical Trial","volume":"111","author":"Donadon","year":"2021","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13346-020-00891-5","article-title":"Intranasal Drug Delivery: Opportunities and Toxicologic Challenges during Drug Development","volume":"12","author":"Keller","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jps.21793","article-title":"Non-Invasive Systemic Drug Delivery: Developability Considerations for Alternate Routes of Administration","volume":"99","author":"Mathias","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/nbt.1504","article-title":"Transdermal Drug Delivery","volume":"26","author":"Prausnitz","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.brainresbull.2018.10.009","article-title":"Evaluation of Intranasal Delivery Route of Drug Administration for Brain Targeting","volume":"143","author":"Bors","year":"2018","journal-title":"Brain Res. Bull."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1056\/NEJMcp1412282","article-title":"Allergic Rhinitis","volume":"372","author":"Wheatley","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_29","first-page":"906","article-title":"Randomized Comparison of Intranasal and Transdermal Estradiol","volume":"96","author":"Lopes","year":"2000","journal-title":"Obstet. Gynecol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"384","DOI":"10.5489\/cuaj.5680","article-title":"The My-T Study: Patient Satisfaction and Preference Comparing Topical and Nasal Testosterone Therapies","volume":"13","author":"Lee","year":"2019","journal-title":"Can. Urol. Assoc. J."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Hanson, L.R., and Frey, W.H. (2008). Intranasal Delivery Bypasses the Blood-Brain Barrier to Target Therapeutic Agents to the Central Nervous System and Treat Neurodegenerative Disease. BMC Neurosci., 9.","DOI":"10.1186\/1471-2202-9-S3-S5"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.yhbeh.2018.05.004","article-title":"Saliva Oxytocin Measures Do Not Reflect Peripheral Plasma Concentrations after Intranasal Oxytocin Administration in Men","volume":"102","author":"Quintana","year":"2018","journal-title":"Horm. Behav."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e62456","DOI":"10.7554\/eLife.62456","article-title":"Salivary and Plasmatic Oxytocin Are Not Reliable Trait Markers of the Physiology of the Oxytocin System in Humans","volume":"9","author":"Martins","year":"2020","journal-title":"Elife"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1038\/s41598-018-21131-4","article-title":"Saliva as a Medium to Detect and Measure Biomarkers Related to Pain","volume":"8","author":"Jasim","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.psyneuen.2012.02.014","article-title":"Intranasal Oxytocin Administration Is Reflected in Human Saliva","volume":"37","author":"Weisman","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.eatbeh.2012.02.004","article-title":"Plasma, Salivary, and Urinary Oxytocin in Anorexia Nervosa: A Pilot Study","volume":"13","author":"Hoffman","year":"2012","journal-title":"Eat. Behav."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1467-7687.2010.01021.x","article-title":"Maternal and Paternal Plasma, Salivary, and Urinary Oxytocin and Parent-Infant Synchrony: Considering Stress and Affiliation Components of Human Bonding","volume":"14","author":"Feldman","year":"2011","journal-title":"Dev. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fnins.2014.00217","article-title":"Urinary Oxytocin Positively Correlates with Performance in Facial Visual Search in Unmarried Males, without Specific Reaction to Infant Face","volume":"8","author":"Saito","year":"2014","journal-title":"Front. Neurosci."},{"key":"ref_39","first-page":"2661","article-title":"Social Vocalizations Can Release Oxytocin in Humans","volume":"277","author":"Seltzer","year":"2010","journal-title":"Proc. Biol. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1196\/annals.1384.006","article-title":"Oxytocin: Behavioral Associations and Potential as a Salivary Biomarker","volume":"1098","author":"Carter","year":"2007","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"12258","DOI":"10.1073\/pnas.1402236111","article-title":"Plasma Oxytocin Concentrations and OXTR Polymorphisms Predict Social Impairments in Children with and without Autism Spectrum Disorder","volume":"111","author":"Parker","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","unstructured":"American Psychiatric Association (2000). American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association. [4th ed.]. Text Revision (DSM-IV-TR)."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.brainres.2014.01.049","article-title":"Intranasal Oxytocin in the Treatment of Autism Spectrum Disorders: A Review of Literature and Early Safety and Efficacy Data in Youth","volume":"1580","author":"Anagnostou","year":"2014","journal-title":"Brain Res."},{"key":"ref_44","unstructured":"First, M.B., Williams, J.B.W., Karg, R.S., and Spitzer, R.L. (2015). Structured Clinical Interview for DSM-5\u2014Research Version (SCID-5-RV, Version 1.0. 0), American Psychiatric Association."},{"key":"ref_45","unstructured":"United States Department of Health and Human Services (1992). Protection of Human Subjects: Title 45, Code of Federal Regulations, Part 46, Department of Health and Human Services. Revised on 18 June 1991."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.psyneuen.2011.02.015","article-title":"A Review of Safety, Side-Effects and Subjective Reactions to Intranasal Oxytocin in Human Research","volume":"36","author":"MacDonald","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.psyneuen.2014.04.006","article-title":"Plasma Oxytocin Concentrations Following MDMA or Intranasal Oxytocin in Humans","volume":"46","author":"Kirkpatrick","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1073\/pnas.0910249107","article-title":"Promoting Social Behavior with Oxytocin in High-Functioning Autism Spectrum Disorders","volume":"107","author":"Andari","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1006\/hbeh.1995.1028","article-title":"The Relationship of Cortisol Levels to Social Environment and Reproductive Functioning in Female Cotton-Top Tamarins, Saguinus Oedipus","volume":"29","author":"Ziegler","year":"1995","journal-title":"Horm. Behav."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/dev.20411","article-title":"Mothers\u2019 and Children\u2019s Concentrations of Oxytocin Following Close, Physical Interactions with Biological and Non-Biological Children","volume":"52","author":"Bick","year":"2010","journal-title":"Dev. Psychobiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.yhbeh.2007.07.005","article-title":"Hormonal Correlates of Human Paternal Interactions: A Hospital-Based Investigation in Urban Jamaica","volume":"52","author":"Gray","year":"2007","journal-title":"Horm. Behav."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"17237","DOI":"10.1073\/pnas.0504767102","article-title":"Early Experience in Humans Is Associated with Changes in Neuropeptides Critical for Regulating Social Behavior","volume":"102","author":"Fries","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jpsychires.2013.12.012","article-title":"Plasma Oxytocin Concentrations Are Lower in Depressed vs. Healthy Control Women and Are Independent of Cortisol","volume":"51","author":"Yuen","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.yhbeh.2006.12.012","article-title":"Non-Invasive Measurement of Small Peptides in the Common Marmoset (Callithrix jacchus): A Radiolabeled Clearance Study and Endogenous Excretion under Varying Social Conditions","volume":"51","author":"Seltzer","year":"2007","journal-title":"Horm. Behav."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.yhbeh.2010.06.014","article-title":"Variation in Oxytocin Is Related to Variation in Affiliative Behavior in Monogamous, Pairbonded Tamarins","volume":"58","author":"Snowdon","year":"2010","journal-title":"Horm. Behav."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neubiorev.2017.04.017","article-title":"The Correlation between Central and Peripheral Oxytocin Concentrations: A Systematic Review and Meta-Analysis","volume":"78","author":"Valstad","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jaac.2012.04.010","article-title":"Examining Autism Spectrum Disorders by Biomarkers: Example From the Oxytocin and Serotonin Systems","volume":"51","author":"Hammock","year":"2012","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.neubiorev.2013.04.018","article-title":"Problems with Measuring Peripheral Oxytocin: Can the Data on Oxytocin and Human Behavior Be Trusted?","volume":"37","author":"McCullough","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.psyneuen.2016.08.011","article-title":"Urinary and Plasma Oxytocin Changes in Response to MDMA or Intranasal Oxytocin Administration","volume":"74","author":"Francis","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nn0602-849","article-title":"Sniffing Neuropeptides: A Transnasal Approach to the Human Brain","volume":"5","author":"Born","year":"2002","journal-title":"Nat. Neurosci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1038\/srep03440","article-title":"Elevated Cerebrospinal Fluid and Blood Concentrations of Oxytocin Following Its Intranasal Administration in Humans","volume":"3","author":"Striepens","year":"2013","journal-title":"Sci. Rep."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.tins.2012.08.004","article-title":"Balance of Brain Oxytocin and Vasopressin: Implications for Anxiety, Depression, and Social Behaviors","volume":"35","author":"Neumann","year":"2012","journal-title":"Trends Neurosci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s42003-020-0799-2","article-title":"RAGE Regulates Oxytocin Transport into the Brain","volume":"3","author":"Yamamoto","year":"2020","journal-title":"Commun. Biol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"7356","DOI":"10.1126\/scitranslmed.aau7356","article-title":"A Randomized Placebo-Controlled Pilot Trial Shows That Intranasal Vasopressin Improves Social Deficits in Children with Autism","volume":"11","author":"Parker","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.biopsych.2015.07.019","article-title":"Vasopressin Boosts Placebo Analgesic Effects in Women: A Randomized Trial","volume":"79","author":"Colloca","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.peptides.2012.07.029","article-title":"Effect of Intranasal Arginine Vasopressin on Human Headache","volume":"38","author":"Yang","year":"2012","journal-title":"Peptides"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pmn.2018.06.001","article-title":"Intranasal Vasopressin Relieves Orthopedic Pain After Surgery","volume":"20","author":"Yang","year":"2019","journal-title":"Pain Manag. Nurs."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"105412","DOI":"10.1016\/j.psyneuen.2021.105412","article-title":"Intranasal Vasopressin like Oxytocin Increases Social Attention by Influencing Top-down Control, but Additionally Enhances Bottom-up Control","volume":"133","author":"Zhuang","year":"2021","journal-title":"Psychoneuroendocrinology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.maturitas.2007.10.004","article-title":"Acute Effect of Intranasal Estrogen on Cerebral and Cerebellar Perfusion in Postmenopausal Women","volume":"59","author":"Kaya","year":"2008","journal-title":"Maturitas"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S0378-5122(01)00200-6","article-title":"Dose-Ranging Studies of a Novel Intranasal Estrogen Replacement Therapy","volume":"38","author":"Panay","year":"2001","journal-title":"Maturitas"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3109\/09513590.2010.501879","article-title":"Cardiovascular Risk Assessment with Oxidised LDL Measurement in Postmenopausal Women Receiving Intranasal Estrogen Replacement Therapy","volume":"27","author":"Kurdoglu","year":"2011","journal-title":"Gynecol. Endocrinol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.neuropharm.2015.06.002","article-title":"Intranasal Delivery of Progesterone after Transient Ischemic Stroke Decreases Mortality and Provides Neuroprotection","volume":"97","author":"Zhang","year":"2015","journal-title":"Neuropharmacology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.psyneuen.2018.04.001","article-title":"Sleep after Intranasal Progesterone vs. Zolpidem and Placebo in Postmenopausal Women\u2014A Randomized, Double-Blind Cross over Study","volume":"92","author":"Kluge","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"108038","DOI":"10.1016\/j.neuropharm.2020.108038","article-title":"Dose-Dependent and Long-Term Cerebroprotective Effects of Intranasal Delivery of Progesterone after Ischemic Stroke in Male Mice","volume":"170","author":"Zhu","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"105046","DOI":"10.1016\/j.yhbeh.2021.105046","article-title":"Development of a Single-Dose Intranasal Testosterone Administration Paradigm for Use in Men and Women","volume":"136","author":"Luberti","year":"2021","journal-title":"Horm. Behav."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2265.1995.tb02929.x","article-title":"Intranasal Administration of the GHRP Hexarelin Accelerates Growth in Short Children","volume":"43","author":"Laron","year":"1995","journal-title":"Clin. Endocrinol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/00016348909087689","article-title":"Efficacy of Gonadotropin-Releasing Hormone Agonist (buserelin) in the Treatment of Endometriosis","volume":"68","author":"Koskimies","year":"1989","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.exger.2010.08.026","article-title":"Intranasal Insulin as a Therapeutic Option in the Treatment of Cognitive Impairments","volume":"46","author":"Benedict","year":"2011","journal-title":"Exp. Gerontol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s40263-013-0076-8","article-title":"Intranasal Insulin as a Treatment for Alzheimer\u2019s Disease: A Review of Basic Research and Clinical Evidence","volume":"27","author":"Freiherr","year":"2013","journal-title":"CNS Drugs"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.neurobiolaging.2005.03.016","article-title":"Effects of Intranasal Insulin on Cognition in Memory-Impaired Older Adults: Modulation by APOE Genotype","volume":"27","author":"Reger","year":"2006","journal-title":"Neurobiol. Aging"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/6\/1178\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:22:34Z","timestamp":1760138554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/6\/1178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,31]]},"references-count":80,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["pharmaceutics14061178"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics14061178","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,31]]}}}